Michigan Medicine reports positive financial performance for fiscal year 2023

9:15 AM

Author | Mary Masson

ANN ARBOR –Michigan Medicine reported projected positive fiscal year-end results today, with an anticipated 0.7 percent ($39.8 million) operating margin on forecasted operating revenues of $5.9 billion.

The results include fiscal 2023 performance from University of Michigan Health, the organization’s clinical branch that includes five hospitals, 125 clinics and the U-M Medical Group, as well as UM Health-West.

These results do not include the impact of the partnership with Sparrow Health System, which was finalized April 1, 2023.

David C. Miller, M.D., M.P.H.,  discussed the current operating environment, along with the fiscal 2024 plan, to the U-M Board of Regents during its regular meeting.

“We focused during fiscal 2023 on our commitment to our patients, families and community through innovation, health equity and improved experience,” said Miller, who is president of University of Michigan Health and executive vice dean for clinical affairs.

“We did not hit our targeted operating margin for fiscal 2023. But despite significant expense pressures related to labor shortages, and revenue increases not keeping pace with inflation, we’ve continued to maintain our high standards of quality and safety for both our patients and staff.

“This takes a level of commitment and teamwork that is not always easy, but the people of Michigan Medicine should be commended for their efforts to make this work.”

Miller said the financial performance still allows capital investments to move forward, like the construction of a new hospital, called The D. Dan and Betty Kahn Health Care Pavilion and the new specialty and mail pharmacy facility in Dexter. Prudent management of cash reserves allow for these investments to continue despite difficult financial circumstances.

The new 12-story hospital will house 264 private rooms capable of converting to intensive care, a state of the art neurological and neurosurgical center, high-level specialty care services for cardiovascular and thoracic patients and advanced imaging services. Construction continues on the 690,000-gross-square-foot building last spring and it is expected to open in fall 2025.

Also planned is the major expansion into specialty and mail pharmacy services, located at a new facility in Dexter. The expansion will allow Michigan Medicine to more than double the number of prescriptions it fills each year through its existing in-house pharmacy.

Marschall S. Runge, M.D., Ph.D., expressed gratitude to Michigan Medicine employees who have successfully managed many challenges including labor market instability and supply chain shortages.

“Our teams are resilient, dedicated, and quick to find innovative solutions for whatever problem arises. I’m grateful for all that our Michigan Medicine employees do every day to make us a health care provider of choice in the state of Michigan,” said Runge, who is CEO of Michigan Medicine, dean of the U-M Medical School and executive vice president for medical affairs for the University of Michigan.

“Our financial results represent their talent and commitment to the highest standards of patient care. In fiscal year 2024, we expect to deliver that exceptional, life-changing care in more than 6 million outpatient visits and nearly 90,000 discharges in our hospitals.”

The Regents also approved a budget that sets Michigan Medicine financial performance targets for the fiscal year that begins July 1. The fiscal year 2024 plan aims for a 0.7 percent operating margin, inclusive of Sparrow Health System.

This financial performance allows Michigan Medicine to continue to invest in people, technology and facilities.

“We will continue to invest in our incredible teams and innovative ways to provide high quality care across the state, including building on our new partnership with Sparrow Health System,” Miller said.

“Recruitment and retention of our workforce and continuing inflation and rising costs will remain challenges in the next year. But we have a team at Michigan Medicine that is ready and willing to do what it takes to maintain the highest standards of patient care.”

About Michigan Medicine: At Michigan Medicine, we advance health to serve Michigan and the world. We pursue excellence every day in our top rated hospitals, clinics and home care operations, as well as educate the next generation of physicians, health professionals and scientists in our U-M Medical School.

Michigan Medicine includes the top ranked U-M Medical School and the University of Michigan Health, which includes the C.S. Mott Children’s Hospital, Von Voigtlander Women’s Hospital, University Hospital, the Frankel Cardiovascular Center, Rogel Cancer Center, U-M Health West and Sparrow Health System. The U-M Medical School is one of the nation's biomedical research powerhouses, with total research funding of more than $500 million.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Featured News & Stories child on comp screen dark room with teddy bar blonde hair
Health Lab
Children often exposed to problematic clickbait during YouTube searches
On YouTube, the content recommended to kids isn’t always age appropriate, a Michigan Medicine study finds.
vines all over growing out of purple woman drawing pink background calendar up and pad on right. calendar says the normal menstrual cycle typically lasts for less than 7 days and occurs every 21 to 35 days. the average woman loses about 2-3 tablespoons of blood during her period. pad says the typical cost the menstrual hygiene products is $7 to $10 per month, which adds up to between $3,360 and $4,800 over the course of a life time
Health Lab
Addressing disparities in abnormal menstrual bleeding and anemia
A large grant for Michigan Medicine will launch important research to improve the screening and treatment for a gynecologic disorder that disproportionately impacts Black and Hispanic populations
woman putting something in vial in lab coat and purple gloves, glasses and mask in clinical looking area
Health Lab
Altering cancer treatment dosing could reduce climate impact, study finds
Changing how often a popular cancer therapy is delivered would reduce greenhouse gas emissions and improve environmental impact without decreasing cancer survival, according to a new analysis from researchers at the University of Michigan Health Rogel Cancer Center.
mom smiling with 3 kids
Health Lab
Adolescents with heart disease learn resilience skills, connect with peers through unique program
Youth with heart disease enrolled in unique program that teaches resilience and builds connections with their peers
Health Lab
Building a sustainable kidney transplant program in Rwanda
A Michigan Medicine surgeon builds a sustainable kidney transplant program in Rwanda.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Presenting: The Fundamentals
Today on Health Lab, we are sharing an episode of The Fundamentals, another podcast from the Michigan Medicine Podcast Network that just launched its second season earlier this month. On this episode of The Fundamentals: "Cannabis and psychedelics: stigmatized substances or powerful therapeutics?" Dr. Kevin Boehnke talks about cannabis, psychedelics, and the increasing body of evidence for their legitimization as therapeutics.